Nigeria, India build partnership to harness opportunities in pharmaceuticals
 Posted Date : 2019-05-27

Import of drugs and pharmaceuticals present growth opportunities and Nigeria is partnering with India to improve patient’s access to medicine as Africa’s most populous nation develops manufacturing capabilities.

Experts say the pharmaceutical sector has great potential if access to high quality drugs in Nigeria is to be attained. 

Import of drugs and pharmaceuticals from India play an important role in the drug distribution chain in Nigeria. 

The Director General of NAFDAC, Mojisola  Adeyeye said that the essence of the exhibition held was to introduce different products from Indian manufacturers to Nigeria and also interact with the manufacturers, letting them know that they are ready to partner with Nigerians for local production. 

She said that Nigeria is ready to build a strong bilateral relationship with the regulators in India and Nigeria is also working toward reducing about 70 % of drugs that are being imported to Nigeria with finished goods to about 30%. She said “we cannot have a universal healthcare especially in medicine without local manufacturing, I encourage us to embrace partnership and we cannot do it alone”.

Nigeria’s predominantly informal distribution and retail networks, counterfeit and parallel medicines are often difficult to deal with. However, opportunities exist for investors to take advantage of the gap in Africa’s largest economy.

“Nigeria is one of the most important exporting destinations for India in the African region with $418 million worth of exports in 2014 – 15.  We have contributed high technology and expertise on board to the industry hence the collaboration,” said udaya Bhaskar, director general pharmexcil.  He said there has been consistency in pharmaceutical export to Nigeria and India for the past 8 – 9 years.  He also said that there is a potential in Nigeria that is why he is encouraging Nigeria pharmaceuticals to collaborate so as to establish the manufacturing industry.  He also spoke on counterfeit and fake drugs stating it’s a global issue hence he urged NAFDAC to address the issues of registration.

Business Day, 17, March 2019